VERY WELL
INFORMED
Latest News
Facts worth knowing from all areas
Decades of expertise in the field of application technology – The Product Development (PD) department of IOI Oleo GmbH
IOI Oleo GmbH is known for its high-quality oleochemical specialities and the technical advice it provides on the use of its products. Thanks to its diversity and longstanding reliability, the product portfolio is used in the pharmaceutical, care, nutrition and technical applications sectors. The R&PD team and its expertise in application development is therefore continuously growing, keeping pace with the demands of the market.
The deluxe touch emollient MIGLYOL® 829 ECO transforms every formulation into a luxurious feel
Lip balm, lipsticks, rich body butters or spa massage oils – these are probably the typical concepts you think of when you already know our MIGLYOL® 829 ECO. With MIGLYOL® 829 ECO, you are not just formulating any old emulsion. You are creating a feeling of luxury and care that your customers will love.
The R&D department of IOI Oleo GmbH supports you – from the idea to the first product
As a leading company in the field of speciality lipids and pharmaceutical oleochemicals, IOI Oleo GmbH develops innovative and sustainable processes, products and formulations at its research centre in Witten.
Trust and transparency – IMWITOR® 742 now with CEP
Product lifecycle management (PLM) for pharmaceuticals ties up considerable capacities in the quality and regulatory departments over the entire lifecycle of the marketing authorisation. Efficient management of information relevant for the authorisation of newly developed, reformulated and generic medicinal products is therefore a significant success factor. In particular, change notifications for the active ingredients and excipients used can cause unforeseeable follow-up costs that are difficult to offset against the most competitive material prices.
Drop it! Kit – Enable innovative concepts to boost your serum routine
The market for serums is currently experiencing an impressive growth phase. According to current forecasts, the "face serum" segment alone will reach a turnover of 11 billion US dollars by 2034, with an annual growth rate of 6.4%. Products with actives (ingredient-led beauty), such as hyaluronic acid, retinol, vitamin C or niacinamide, are particularly in demand.